These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Oral administration of haloperidol at clinically recommended doses elicits smaller parkinsonian effects but more tardive dyskinesia in rats. Shireen E, Naeem S, Inam QU, Haleem DJ. Pak J Pharm Sci; 2013 Mar; 26(2):271-6. PubMed ID: 23455196 [Abstract] [Full Text] [Related]
25. Reversal of neuroleptic-induced orofacial dyskinesia by 5-HT3 receptor antagonists. Naidu PS, Kulkarni SK. Eur J Pharmacol; 2001 May 25; 420(2-3):113-7. PubMed ID: 11408032 [Abstract] [Full Text] [Related]
26. Tardive dyskinesia: are first signs reversible? Quitkin F, Rifkin A, Gochfeld L, Klein DF. Am J Psychiatry; 1977 Jan 25; 134(1):84-7. PubMed ID: 12666 [Abstract] [Full Text] [Related]
34. Tardive dyskinesia and current dose of neuroleptic drugs. Kolakowska T, Williams AO, Ardern M. Arch Gen Psychiatry; 1986 Jun 25; 43(6):614. PubMed ID: 2871820 [No Abstract] [Full Text] [Related]